These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21458999)

  • 1. QSAR-based permeability model for drug-like compounds.
    Gozalbes R; Jacewicz M; Annand R; Tsaioun K; Pineda-Lucena A
    Bioorg Med Chem; 2011 Apr; 19(8):2615-24. PubMed ID: 21458999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR-based solubility model for drug-like compounds.
    Gozalbes R; Pineda-Lucena A
    Bioorg Med Chem; 2010 Oct; 18(19):7078-84. PubMed ID: 20810286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new topological descriptors based model for predicting intestinal epithelial transport of drugs in Caco-2 cell culture.
    Marrero Ponce Y; Cabrera Pérez MA; Romero Zaldivar V; González Díaz H; Torrens F
    J Pharm Pharm Sci; 2004 Jun; 7(2):186-99. PubMed ID: 15367375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting permeability coefficient in ADMET evaluation by using different membranes-interaction QSAR.
    Liu J; Li Y; Pan D; Hopfinger AJ
    Int J Pharm; 2005 Nov; 304(1-2):115-23. PubMed ID: 16182478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR study on permeability of hydrophobic compounds with artificial membranes.
    Fujikawa M; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Provisional classification and in silico study of biopharmaceutical system based on caco-2 cell permeability and dose number.
    Pham-The H; Garrigues T; Bermejo M; González-Álvarez I; Monteagudo MC; Cabrera-Pérez MÁ
    Mol Pharm; 2013 Jun; 10(6):2445-61. PubMed ID: 23675957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADME evaluation in drug discovery. 5. Correlation of Caco-2 permeation with simple molecular properties.
    Hou TJ; Zhang W; Xia K; Qiao XB; Xu XJ
    J Chem Inf Comput Sci; 2004; 44(5):1585-600. PubMed ID: 15446816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
    Akamatsu M; Fujikawa M; Nakao K; Shimizu R
    Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction and mechanistic interpretation of human oral drug absorption using MI-QSAR analysis.
    Iyer M; Tseng YJ; Senese CL; Liu J; Hopfinger AJ
    Mol Pharm; 2007; 4(2):218-31. PubMed ID: 17397237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthogonal chromatographic descriptors for modelling Caco-2 drug permeability.
    Deconinck E; Verstraete T; Van Gyseghem E; Vander Heyden Y; Coomans D
    J Chromatogr Sci; 2012 Mar; 50(3):175-83. PubMed ID: 22337793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
    Martin E; Mukherjee P; Sullivan D; Jansen J
    J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative structure-activity relationship (QSAR) study of dermal absorption using theoretical molecular descriptors.
    Basak SC; Mills D; Mumtaz MM
    SAR QSAR Environ Res; 2007; 18(1-2):45-55. PubMed ID: 17365958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the role of different drug transport routes in permeability screening.
    Matsson P; Bergström CA; Nagahara N; Tavelin S; Norinder U; Artursson P
    J Med Chem; 2005 Jan; 48(2):604-13. PubMed ID: 15658873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the 96 well Caco-2 cell culture model for high throughput permeability assessment of discovery compounds.
    Marino AM; Yarde M; Patel H; Chong S; Balimane PV
    Int J Pharm; 2005 Jun; 297(1-2):235-41. PubMed ID: 15907606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay.
    Lee PH; Conradi R; Shanmugasundaram V
    Bioorg Med Chem Lett; 2010 Jan; 20(1):69-73. PubMed ID: 19963379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability.
    Fujikawa M; Ano R; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2005 Aug; 13(15):4721-32. PubMed ID: 15936203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based prediction of human intestinal membrane permeability for rapid in silico BCS classification.
    Sun L; Liu X; Xiang R; Wu C; Wang Y; Sun Y; Sun J; He Z
    Biopharm Drug Dispos; 2013 Sep; 34(6):321-35. PubMed ID: 23716273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting MDCK cell permeation coefficients of organic molecules using membrane-interaction QSAR analysis.
    Chen LL; Yao J; Yang JB; Yang J
    Acta Pharmacol Sin; 2005 Nov; 26(11):1322-33. PubMed ID: 16225754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of predictive QSAR models to database mining: identification and experimental validation of novel anticonvulsant compounds.
    Shen M; Béguin C; Golbraikh A; Stables JP; Kohn H; Tropsha A
    J Med Chem; 2004 Apr; 47(9):2356-64. PubMed ID: 15084134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the permeability of drugs and drug-like molecules from MI-QSAR and HQSAR studies.
    Shinde RN; Srikanth K; Sobhia ME
    J Mol Model; 2012 Mar; 18(3):947-62. PubMed ID: 21638045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.